Height, Ulnar Length and Forearm Function in Multiple Hereditary Exostoses

Sponsor
Istituto Ortopedico Rizzoli (Other)
Overall Status
Completed
CT.gov ID
NCT05914298
Collaborator
(none)
408
1
49
8.3

Study Details

Study Description

Brief Summary

the purpose of the present registry is to describe the epidemiology of forearm deformities in patients with Hereditary Multiple Exostoses and to identify, independent predictors of severity of the disease and potential association with genotypic patterns

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: blood and buccal swab genetic test
  • Diagnostic Test: PUL
  • Diagnostic Test: Range of motion

Detailed Description

Hereditary Multiple Exostoses (HME) is a rare pediatric autosomal dominant disorder caused by loss-of-function mutations in the genes encoding the heparan sulfate (HS)-synthesizing enzymes EXT1 or EXT2. HME affects 1 in 50,000 people and has 100% penetrance but great variability in phenotypic expression. HME is characterized by formation of cartilaginous outgrowths, called osteochondromas or exostoses, next to the growth plates of many axial and appendicular skeletal elements, causing multiple, painful disfiguring and disabling skeletal deformities, and potential malignant transformation into peripherral chondrosarcoma.

The involvement of upper-limb bones by HME is associated with greater loss of function than elsewhere in the body, but even here the loss of function may be limited. Moreover, the constant relationship between height and ulnar length has long been recognized in forensic medicine and has been recently analyzed also in HME, in order to predict the clinical and functional outcomes of the upper limb.

the present registry aims to collect demographic, clinical, functional and radiographic information from patients with HME in order to establish phenotypic predictors of severity of the disease and potential association with genotypic patterns

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
408 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Analysis of the Relationship Among Height, Ulnar Length and Forearm Function in Patients With Multiple Hereditary Exostoses and Association With the Genotypic Pattern
Actual Study Start Date :
Jan 1, 2018
Actual Primary Completion Date :
Feb 1, 2021
Actual Study Completion Date :
Feb 1, 2022

Arms and Interventions

Arm Intervention/Treatment
HME group

204 children and adult patients with HME, admitted to our Hospital for diagnosis and treatment. the patients will be stratified by age in four subgroups: subgroup I (0-7 Years) subgroup II (8-12 Years) subgroup III (13-18 Years) subgroup IV (>18 Years)

Diagnostic Test: blood and buccal swab genetic test
blood samples and buccal swabs will be obtained from patients with HME in order to analyze the genotype (EXT1 or EXT2 mutations) and correlate the genotypic pattern with the phenotypic presentation

Diagnostic Test: PUL
measurement of ulnar length with anthropometer and patient's height

Diagnostic Test: Range of motion
measurement of range of motion of elbow, forearm and wrist

healty control group

204 children and adult voluntary healty controls will be stratified in the same manner and matched with the population in study in order to assess normal and pathologic growth.

Diagnostic Test: PUL
measurement of ulnar length with anthropometer and patient's height

Diagnostic Test: Range of motion
measurement of range of motion of elbow, forearm and wrist

Outcome Measures

Primary Outcome Measures

  1. proportional ulnar length (PUL) [1 year]

    proportional ulnar length (PUL) is the ratio between ulnar lenght and the height of the patient

Secondary Outcome Measures

  1. genotype [1 year]

    identify potential association among the genotypic pattern (EXT1 or EXT2) and phenotypic presentation

  2. forearm function [1 year]

    elbow, forearm and wrist range of motion (ROM) measured by a goneometer

  3. EuroQol 5D [1 year]

    EQ-5D is a standardised measure of health-related quality of life developed by the EuroQol Group

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • patients with HME (> 2 exostoses)
Exclusion Criteria:
  • Patients with solitary exostoses

  • Patients, adults or minors, who are unable to give their timely informed consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Manila Boarini Bologna Italy 40136

Sponsors and Collaborators

  • Istituto Ortopedico Rizzoli

Investigators

  • Principal Investigator: Giovanni Luigi Di Gennaro, MD, Istituto Ortopedico Rizzoli

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Istituto Ortopedico Rizzoli
ClinicalTrials.gov Identifier:
NCT05914298
Other Study ID Numbers:
  • 0012479
First Posted:
Jun 22, 2023
Last Update Posted:
Jun 22, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Istituto Ortopedico Rizzoli
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 22, 2023